Bio-ELISA Assay for Low-Level TH Protein Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The lack of a robust and sensitive assay to measure low levels of tyrosine hydroxylase (TH) protein in peripheral immune cells hampers the investigation of TH levels in diseases characterized by altered catecholamine tone, such as Parkinson's disease, where changes in TH levels in immune cells are difficult to detect due to their low expression.
Innovation Solution
A sensitive Bio-ELISA assay is developed using specific antibodies to detect and quantify TH protein in peripheral monocytes, achieving a detection threshold of 15 pg/mL, significantly improving the sensitivity and specificity compared to traditional methods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional measurement methods are used, then the assay is simpler to perform, but the detection sensitivity is insufficient to measure low levels of TH protein in peripheral immune cells
Solution Approach 1:
The assay is divided into multiple sequential steps including sample preparation, antibody incubation, washing, and detection phases. This segmentation allows each step to be optimized for sensitivity while maintaining overall manageability of the complex procedure
Solution Approach 2:
The patent uses biotinylated detection antibodies and HRP-conjugated streptavidin as intermediary components to amplify the detection signal. This intermediary system enables highly sensitive detection of low-abundance TH protein through signal amplification mechanisms
2Measurement precision
If indirect TH measurements via qPCR are used, then the measurement can be performed, but the results do not directly quantify TH protein levels in immune cells
Solution Approach 1:
The patent replaces indirect molecular measurement (qPCR) with direct protein detection using ELISA methodology. This substitution provides actual TH protein quantification rather than inferring protein levels from mRNA measurements, directly resolving the measurement difficulty through a dedicated protein detection system
3Loss of information
If TH levels in immune cells are measured, then insights into catecholamine regulation can be obtained, but the low expression levels make detection difficult
Solution Approach 1:
The use of biotinylated antibodies and HRP-conjugated streptavidin creates an intermediary amplification system that converts low-abundance TH protein signals into detectable colorimetric or chemiluminescent signals, preventing information loss while maintaining measurement precision
Solution Approach 2:
The assay employs parameter optimization including antibody concentration gradients, incubation time variations, and signal amplification factors to enhance detection capability for low-expression TH protein while preserving accurate biological information
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The Bio-ELISA assay allows for the reliable quantification of TH protein in various cell types and tissues, revealing elevated TH levels in Parkinson's disease patients, and demonstrates that TNFα increases TH expression in monocytes, providing insights into the underlying mechanisms of catecholamine regulation in immune cells.
Implementation Method 1
subjecting the combination to horse radish peroxidase conjugated with avidin (HRP-avidin), wherein contact between HRP-avidin and biotinylated anti-TH antibody is made under conditions to produce a colorimetric signal
Implementation Method 2
contact between HRP-avidin and biotinylated anti-TH antibody is made under conditions to produce a colorimetric signal
Implementation Method 3
horse radish peroxidase conjugated with avidin (HRP-avidin), wherein contact between HRP-avidin and biotinylated anti-TH antibody is made under conditions to produce a colorimetric signal
Data Source
AI summary
Disclosed is a method for detecting a level of tyrosine hydroxy lase (TH) in a biosample from a subject. The biosample comprises a homogenate of peripheral monocytes from the subject. Detection involves conducting an ELISA on the biosample using a biotinylated anti-TH antibody under conditions to allow the biotinylated anti-TH antibody to bind to TH. If elevated TH is detected, an amount of a TNFα inhibitor effective to decrease TH in peripheral monocytes of the subject may be administered. In a particular method, a TNFα inhibitor is administered if the TH level in the biosample is higher than a threshold level.